X @Forbes

"I think regulators are coming around."Sabeen Mekan, M.D., Senior Vice President of Clinical Development at Zymeworks, spoke about the current state of regulation around medical trials when considering personalized medicine at the #ForbesHealth Summit. https://t.co/J5zmYAGP1E ...